Cerebrolysin
What it is
Cerebrolysin is not a single peptide but a standardized mixture of low-molecular-weight neuropeptides and free amino acids produced by enzymatic hydrolysis of purified porcine (pig) brain proteins. The peptide fragments in the mixture are generally below 10 kilodaltons, and it is often described as a neurotrophic or neuropeptide preparation.
Research context and categorization
Cerebrolysin is grouped under the cognitive and neuroprotective (neurotrophic) research category. In the published literature it is commonly discussed in relation to neuronal survival, neuroplasticity, and central nervous system recovery, and it has been investigated for stroke rehabilitation, traumatic brain injury, and various forms of dementia including Alzheimer-type cognitive decline. It is also sometimes discussed in the context of general cognitive support.
These uses are investigational from a United States regulatory standpoint and should not be treated as confirmed or established benefits. The evidence base is mixed. Some dementia trials have reported apparent benefit, while a major stroke trial did not meet its primary endpoint, and systematic reviews have rated much of the pooled evidence as low quality and flagged signals worth further scrutiny. In short, Cerebrolysin is studied and debated rather than settled, and outcomes described in the literature remain unconfirmed and unapproved in the United States.
Status
- Regulatory status: Research-only in the United States. Cerebrolysin is not FDA-approved for any indication. It is marketed and approved in roughly 50 other countries (largely in Europe and Asia) for indications such as stroke, traumatic brain injury, and dementia, but that foreign approval does not apply in the United States.
- Sport status: Not specifically listed on the WADA Prohibited List. Cerebrolysin does not appear as a named substance and is not identified as a prohibited peptide hormone or growth factor. Because the WADA Prohibited List is revised annually and carries catch-all language for related substances, current status should be reverified against the latest list before any competition context.
Reconstitution notes (general)
For a standard lyophilized (freeze-dried) research peptide, concentration equals the milligrams of compound in the vial divided by the millilitres of bacteriostatic water added. For example, 60 mg mixed with 2 mL of bacteriostatic water gives a concentration of 30 mg per mL. A reconstitution calculator is available at /pages/tools. Note that this general powder formula does not describe how Cerebrolysin is typically supplied (see below).
Dilution and handling notes (compound-specific)
Cerebrolysin is an exception to the usual reconstitution workflow. It is generally supplied as a ready-to-use aqueous solution in sealed glass ampoules (for example 2 mL, 5 mL, or 10 mL amber ampoules), not as a lyophilized powder that requires mixing with bacteriostatic water. Because it already arrives in solution, there is normally no reconstitution step, no powder to dissolve, and no gelling, clouding, or precipitation-on-concentration issue of the kind seen with some concentrated peptide powders.
Where dilution is discussed in reference material, it applies only to larger volumes intended for slow infusion, in which case the ampoule solution is combined with a compatible carrier such as 0.9% sodium chloride (saline), 5% glucose solution, or Ringer's lactate immediately before use. The solution is meant to be used promptly once an ampoule is opened, since an opened ampoule is no longer a sealed sterile unit and it is not preserved for extended open storage. One handling quirk to note is that it is a clear amber-tinted liquid, so the visual baseline for "looks wrong" differs from a colorless reconstituted peptide, and any diluted preparation is treated as single-use rather than stored.
Handling and storage
General cold-chain handling for this class is to keep the material refrigerated at roughly 2 to 8 degrees Celsius, stored out of direct light, and protected from freezing. For any vial or ampoule accessed through a rubber stopper, wipe the stopper with an alcohol swab before access and label the container with the date it was opened or mixed. Reconstituted or opened peptide solutions are commonly assigned a refrigerated working window of about four weeks, though ready-to-use ampoule solutions are typically single-use once opened. Discard any solution that becomes cloudy, changes color beyond its normal appearance, or shows particulates or floaters.
Related reading
Tools and supplies
- Reconstitution & blend calculators
- Bacteriostatic Water 30 ml
- Gansulin Metal Reusable Pen
- 3 ml Glass Cartridges (10-pack)
- Complete Starter Kit
For laboratory and research reference only. Educational content, not medical, dosing, injection, or therapeutic guidance, and not intended for human or animal use. Any research uses described are investigational and not confirmed or approved benefits. Confirm anything involving health with a licensed professional. References linked above.